Community Physicians Pledge Commitment to the Cancer Center at NGMC
Published on May 22, 2013Northeast Georgia Medical Center (NGMC) hosted a “signing day” event this morning to recognize physicians who have made a dedicated effort to further improving the health and treatment experience of cancer patients in the community.
“We recognize the importance of coordination of care, as cancer patients, more than any other, must navigate a myriad of physician specialists and treatments,” says Charles Nash, III, MD, a medical oncologist with The Longstreet Clinic and medical director of the Cancer Center at NGMC. “Our hope is to build a unified system of physicians for which coordination of care is handled efficiently and effectively across all specialties.”
Physicians, including medical oncologists, radiation oncologists, surgeons and other specialists, signed an agreement intended to further improve patient care quality and access to cancer services at NGMC.
As a physician of the Cancer Center at NGMC, signees are agreeing to adhere to a number of best practice patient care guidelines such as attending tumor conferences in which physicians from different specialties collaborate to determine a best treatment plan for specific patient cases; participating in Cancer Center sponsored activities such as educational seminars, screenings or other outreach; and participating in charitable care.
“Our goal is to build further collaboration among our cancer physicians for the betterment of our patients,” says Brad Nurkin, President of NGMC. “This collaboration and coordination also better prepares us for the new requirements of healthcare reform.”
ABOUT THE CANCER CENTER AT NGMC:
The Cancer Center at Northeast Georgia Medical Center is accredited with commendation by the American College of Surgeons’ Commission on Cancer as a Comprehensive Community Cancer Program – their highest level of accreditation. The Cancer Center also offers approximately 60 ongoing cancer clinical trials, ensuring that patients throughout northeast Georgia have access to the latest research advances in cancer treatment.